Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Concert began a double-blind, placebo-controlled, U.S. Phase II trial to evaluate 600 mg oral CTP-499 twice daily for 24 weeks in about 170 Type II diabetics with chronic kidney disease (CKD) who are ...